• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光动力疗法在复发性生殖器疱疹中的应用。

The application of photodynamic therapy in recurrent genital herpes.

作者信息

Chen Jinyi, Li Yuancheng, Li Dechao, Chen Nian, Ding Wen, Zou Ting, Tan Yang, Lei Xia

机构信息

Department of Dermatology, Daping Hospital, Army Medical University(Third Military Medical University), No.10, Yangtze River Branch Road, Daping, Yuzhong District, Chongqing, 400042, China; Research Center for Skin Tissue Engineering of Chongqing Higher Education Institutions, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, 400042, China.

Department of Dermatology, Daping Hospital, Army Medical University(Third Military Medical University), No.10, Yangtze River Branch Road, Daping, Yuzhong District, Chongqing, 400042, China; Research Center for Skin Tissue Engineering of Chongqing Higher Education Institutions, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, 400042, China; Engineering Research Center of the Ministry of Education for Tissue and Organ Regeneration and Manufacturing, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, 400042, China.

出版信息

Photodiagnosis Photodyn Ther. 2024 Dec;50:104386. doi: 10.1016/j.pdpdt.2024.104386. Epub 2024 Oct 30.

DOI:10.1016/j.pdpdt.2024.104386
PMID:39481741
Abstract

BACKGROUND

Frequently, recurrence of genital herpes imposes significant physical and psychological burdens on patients, and existing treatments are often ineffective in preventing recurrence. Previous studies have indicated that photodynamic therapy (PDT) showed promising outcomes in the treatment of labial herpes simplex virus (HSV) infections; however, its efficacy for genital herpes remained unclear.

METHOD

The study screened patients with genital herpes at Daping Hospital from July 2020 to May 2024. Patients were divided into two groups based on whether they received PDT treatment. Over a one-year follow-up period, patients' healing time and recurrence rates were compared between the two groups. The cumulative incidence of recurrence and restricted mean survival time (RMST) were used to assess outcomes. Propensity score matching (PSM) was employed to minimize bias.

RESULT

A total of 41 patients enrolled in our study, with 8 (19.5 %) received PDT. The non-PDT group exhibited a slower skin lesion healing time, averaging at 7.2 days compared to 5.4 days in the PDT group. A significant difference was observed in the cumulative incidence of recurrence between the PDT and non-PDT groups (37.5 % versus 71.4 %) after PSM. The RMST in the PDT group was 9.94 days, compared to 5.13 days in the non-PDT group before PSM, and 4.14 after PSM.

CONCLUSION

Our study demonstrated that the PDT effectively reduced lesion recovery time and delayed recurrences of genital herpes. We recommend considering PDT as a potential treatment option for patients with recurrent genital herpes.

摘要

背景

生殖器疱疹的复发常常给患者带来巨大的身心负担,并且现有的治疗方法在预防复发方面往往效果不佳。先前的研究表明,光动力疗法(PDT)在治疗唇疱疹单纯病毒(HSV)感染方面显示出有前景的结果;然而,其对生殖器疱疹的疗效仍不明确。

方法

该研究对2020年7月至2024年5月在大坪医院的生殖器疱疹患者进行了筛查。根据患者是否接受PDT治疗将其分为两组。在一年的随访期内,比较两组患者的愈合时间和复发率。采用复发的累积发生率和受限平均生存时间(RMST)来评估结果。使用倾向得分匹配(PSM)来最小化偏差。

结果

共有41名患者纳入我们的研究,其中8名(19.5%)接受了PDT治疗。非PDT组的皮肤病变愈合时间较慢,平均为7.2天,而PDT组为5.4天。PSM后,PDT组和非PDT组之间的复发累积发生率存在显著差异(37.5%对71.4%)。PDT组的RMST为9.94天,PSM前非PDT组为5.13天,PSM后为4.14天。

结论

我们的研究表明,PDT有效地缩短了生殖器疱疹的病变恢复时间并延迟了复发。我们建议将PDT视为复发性生殖器疱疹患者潜在治疗选择。

相似文献

1
The application of photodynamic therapy in recurrent genital herpes.光动力疗法在复发性生殖器疱疹中的应用。
Photodiagnosis Photodyn Ther. 2024 Dec;50:104386. doi: 10.1016/j.pdpdt.2024.104386. Epub 2024 Oct 30.
2
Photodynamic therapy and Acyclovir in the treatment of recurrent herpes labialis: A controlled randomized clinical trial.光动力疗法与阿昔洛韦治疗复发性唇疱疹:一项对照随机临床试验。
Photodiagnosis Photodyn Ther. 2021 Mar;33:102093. doi: 10.1016/j.pdpdt.2020.102093. Epub 2020 Nov 16.
3
Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time.随着时间推移,生殖器单纯疱疹病毒感染的临床再激活频率会降低。
Ann Intern Med. 1999 Jul 6;131(1):14-20. doi: 10.7326/0003-4819-131-1-199907060-00004.
4
Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.免疫功能正常的非妊娠患者预防生殖器疱疹发作的口服抗病毒治疗。
Cochrane Database Syst Rev. 2014 Aug 3;2014(8):CD009036. doi: 10.1002/14651858.CD009036.pub2.
5
Intravenous acyclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial.静脉注射阿昔洛韦治疗初发性生殖器疱疹:一项多中心双盲、安慰剂对照试验。
Am J Med. 1988 Sep;85(3):301-6. doi: 10.1016/0002-9343(88)90578-5.
6
Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group.口服泛昔洛韦抑制复发性生殖器疱疹:一项随机对照试验。泛昔洛韦生殖器疱疹协作研究组
JAMA. 1998 Sep 9;280(10):887-92. doi: 10.1001/jama.280.10.887.
7
Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.伐昔洛韦对免疫功能正常的复发性2型单纯疱疹病毒生殖器疱疹患者病毒排出的影响:一项美国的随机、双盲、安慰剂对照临床试验。
Mayo Clin Proc. 2006 Oct;81(10):1321-7. doi: 10.4065/81.10.1321.
8
Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections.局部用阿昔洛韦治疗单纯疱疹病毒生殖器感染的双盲对照试验
Am J Med. 1982 Jul 20;73(1A):326-34. doi: 10.1016/0002-9343(82)90117-6.
9
Herpes Simplex Virus Shedding Rate: Surrogate Outcome for Genital Herpes Recurrence Frequency and Lesion Rates, and Phase 2 Clinical Trials End Point for Evaluating Efficacy of Antivirals.单纯疱疹病毒脱落率:生殖器疱疹复发频率和病变率的替代结局,以及评估抗病毒药物疗效的 2 期临床试验终点。
J Infect Dis. 2018 Oct 20;218(11):1691-1699. doi: 10.1093/infdis/jiy372.
10
An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.一项关于伐昔洛韦用于抑制新诊断患者单纯疱疹病毒2型生殖器疱疹的国际、随机、双盲、安慰剂对照研究。
Sex Transm Dis. 2008 Jul;35(7):668-73. doi: 10.1097/OLQ.0b013e31816d1f42.